French portable ultrasound developer Sonoscanner has received U.S. Food and Drug Administration (FDA) clearance for its U-Lite EXP scanner.
U-Lite EXP is the second generation of the company's U-Lite ultraportable scanner platform, which was first introduced in the U.S. in 2015. The new version offers better diagnostic performance and improved image definition, according to the company.
Sonoscanner's U-Lite EXP scanner. Image courtesy of Sonoscanner.The new system incorporates 256-element 18-MHz probes, which assist in the diagnosis of small breast tumors or musculoskeletal diseases. It includes six high-definition interchangeable problems and is suited for clinical applications in gynecology, obstetrics, urology, anesthesia, endocrinology, osteoarticular, and general medicine. The unit is lightweight, weighing in at 600 grams, and includes a touchscreen interface, the vendor stated.
The company sees U-Lite EXP as the key to its goal of penetrating the U.S. ultrasound market; the company plans to showcase the system at the Journées Francophones de Radiologie (JFR) 2017 congress in Paris on 13-16 October and at the RSNA 2017 meeting.
